Vertex Pharmaceuticals Incorporated (LON:0QZU)
London
· Delayed Price · Currency is GBP · Price in USD 454.69
-5.81 (-1.26%)
Dec 5, 2025, 5:08 PM BST
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 86.74 billion as of December 5, 2025. Its market cap has decreased by -8.81% in one year.
Market Cap
86.74B
Enterprise Value
79.10B
Revenue
8.72B
Ranking
n/a
PE Ratio
31.72
Stock Price
454.69
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 51.21M to 86.74B, an increase of 169,271.42%. That is a compound annual growth rate of 24.13%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 214.00B |
| GSK plc | 73.02B |
| Haleon | 32.85B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.90B |
| Genus | 1.75B |